Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Resistance of Cancer Cells to CTL-Mediated Immunotherapy by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319178073
Publisher: Springer International Publishing Publication: June 20, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319178073
Publisher: Springer International Publishing
Publication: June 20, 2015
Imprint: Springer
Language: English

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

More books from Springer International Publishing

Cover of the book EPSA15 Selected Papers by
Cover of the book Knowledge Management in the Sharing Economy by
Cover of the book Neo-Colonialism and the Poverty of 'Development' in Africa by
Cover of the book Probability Distributions in Risk Management Operations by
Cover of the book Operations Research and Enterprise Systems by
Cover of the book Human Dignity of the Vulnerable in the Age of Rights by
Cover of the book Basic Earthquake Engineering by
Cover of the book Treating Adolescents with Family-Based Mindfulness by
Cover of the book Asia-Pacific Security Challenges by
Cover of the book Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology by
Cover of the book Atlas of Head and Neck Endocrine Disorders by
Cover of the book Modification of K0s and Lambda(AntiLambda) Transverse Momentum Spectra in Pb-Pb Collisions at √sNN = 2.76 TeV with ALICE by
Cover of the book Analysis by
Cover of the book Models, Methods, and Tools for Complex Chip Design by
Cover of the book Hybrid Soft Computing for Multilevel Image and Data Segmentation by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy